Disease-Free SurvivalSurvival RatePrognosisNeoplasm StagingTreatment OutcomeRetrospective StudiesSurvival AnalysisNeoplasm Recurrence, LocalBreast NeoplasmsCombined Modality TherapyKaplan-Meier EstimateFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsTumor Markers, BiologicalChemotherapy, AdjuvantLymphatic MetastasisRadiotherapy, AdjuvantImmunohistochemistryCell SurvivalProportional Hazards ModelsRadiotherapy DosageTime FactorsFluorouracilCarcinoma, Squamous CellNeoplasm InvasivenessCyclophosphamideColorectal NeoplasmsCarcinoma, Ductal, BreastRecurrenceMultivariate AnalysisCarcinomaLiver NeoplasmsRisk FactorsAdenocarcinomaImmunoenzyme TechniquesReceptors, EstrogenProspective StudiesDiseaseReceptor, erbB-2Genetic Predisposition to DiseaseGenetic Diseases, InbornGenome-Wide Association StudyPredictive Value of TestsPolymorphism, Single NucleotideGene Expression Regulation, NeoplasticSurvivalGenome, HumanNeoplasm MetastasisCisplatinGenetic VariationLung NeoplasmsAntineoplastic AgentsGraft SurvivalCohort StudiesNeoplasm GradingVincristineGenetics, MedicalMultifactorial InheritanceGenotypeHaplotypesModels, GeneticDoxorubicinLinkage DisequilibriumNeoadjuvant TherapyBone NeoplasmsRemission InductionDisease ProgressionAge FactorsEtoposideCase-Control StudiesChemoradiotherapyDrug Administration ScheduleCarcinoma, Non-Small-Cell LungOvarian NeoplasmsSalvage TherapyRare DiseasesReceptors, ProgesteroneGene FrequencyAllelesMethotrexateGenetic TestingSarcomaRadiotherapyGenetic LinkageHead and Neck NeoplasmsRisk AssessmentFree RadicalsLymphoma, Non-HodgkinPrednisoneLymph Node ExcisionBrachytherapyActuarial AnalysisMutationCarboplatinGenetics, PopulationHodgkin DiseaseGenetic LociCarcinoma, HepatocellularLymph NodesFounder Effect